Guidelines of Guidelines: Conservative, Pharmacological, and Surgical Management for Neurogenic Lower Urinary Tract Dysfunction

TL;DR

This paper compares guidelines for managing neurogenic lower urinary tract dysfunction to highlight differences in treatment recommendations.

Contribution

The study systematically reviews and summarizes management recommendations from major NLUTD guidelines.

Findings

Prominent guidelines differ in their recommendations for NLUTD management.

Recommendations cover conservative, pharmacological, and surgical approaches.

Discrepancies arise due to limited high-quality clinical evidence.

Abstract

Neurogenic lower urinary tract dysfunction (NLUTD) encompasses a broad spectrum of neurological conditions affecting the lower urinary tract. Managing NLUTD requires a tailored approach focused on preserving kidney function and enhancing patients’ quality of life. Clinical guidelines provide valuable guidance for healthcare professionals, but discrepancies in recommendations arise among other factors due to limited high-quality clinical evidence. Prominent guidelines from organisations like the International Consultation of Incontinence, the European Association of Urology, the American Urological Association, and the National Institute for Health and Care Excellence offer varying recommendations for NLUTD management. This study reviews and summarizes the recommendations for conservative, pharmacological, and surgical management options across these guidelines.

Figures